{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:03:26Z","timestamp":1768737806706,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T00:00:00Z","timestamp":1380931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s12012-013-9230-2","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T16:19:46Z","timestamp":1380903586000},"page":"30-40","source":"Crossref","is-referenced-by-count":40,"title":["Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment"],"prefix":"10.1007","volume":"14","author":[{"given":"Luciana Grazziotin","family":"Rossato","sequence":"first","affiliation":[]},{"given":"Vera Marisa","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Eliane","family":"Dallegrave","sequence":"additional","affiliation":[]},{"given":"Marcelo","family":"Arbo","sequence":"additional","affiliation":[]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Amado","sequence":"additional","affiliation":[]},{"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Alberto","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Maria","family":"de Lourdes Bastos","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Palmeira","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,10,5]]},"reference":[{"key":"9230_CR1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.4.2.219","volume":"4","author":"K Seiter","year":"2005","unstructured":"Seiter, K. (2005). Toxicity of the topoisomerase II inhibitors. Expert Opinion on Drug Safety, 4, 219\u2013234.","journal-title":"Expert Opinion on Drug Safety"},{"key":"9230_CR2","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/WNL.0b013e3181e0f7e6","volume":"74","author":"E Kingwell","year":"2010","unstructured":"Kingwell, E., Koch, M., Leung, B., Isserow, S., Geddes, J., Rieckmann, P., et al. (2010). Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS. Neurology, 74, 1822\u20131826.","journal-title":"Neurology"},{"key":"9230_CR3","doi-asserted-by":"crossref","unstructured":"Avasarala, J. R., Cross, A. H., Clifford, D. B., Singer, B. A., Siegel, B. A., & Abbey, E. E. (2003). Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis. Multiple Sclerosis, 9, 59\u201362.","DOI":"10.1191\/1352458503ms896oa"},{"key":"9230_CR4","first-page":"4850","volume":"53","author":"P Canal","year":"1993","unstructured":"Canal, P., Attal, M., Chatelut, E., Guichard, S., Huguet, F., Muller, C., et al. (1993). Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas. Cancer Research, 53, 4850\u20134854.","journal-title":"Cancer Research"},{"key":"9230_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003088-199018050-00003","volume":"18","author":"G Ehninger","year":"1990","unstructured":"Ehninger, G., Schuler, U., Proksch, B., Zeller, K. P., & Blanz, J. (1990). Pharmacokinetics and metabolism of mitoxantrone. A review. Clinical Pharmacokinetics, 18, 365\u2013380.","journal-title":"Clinical Pharmacokinetics"},{"key":"9230_CR6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602538608998294","volume":"17","author":"VK Batra","year":"1986","unstructured":"Batra, V. K., Morrison, J. A., Woodward, D. L., Siverd, N. S., & Yacobi, A. (1986). Pharmacokinetics of mitoxantrone in man and laboratory animals. Drug Metabolism Reviews, 17, 311\u2013329.","journal-title":"Drug Metabolism Reviews"},{"key":"9230_CR7","doi-asserted-by":"crossref","unstructured":"Rossato, L., Costa, V. M., De Pinho, P., Freitas, V., Viloune, L., Bastos, M., et al. (2013). The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity. Archives of Toxicology, 10, 1809\u20131820. doi: 10.1007\/s00204-013-1040-6 .","DOI":"10.1007\/s00204-013-1040-6"},{"key":"9230_CR8","doi-asserted-by":"crossref","unstructured":"Rossato, L. G., Costa, V. M., Villas-Boas, V., de Lourdes Bastos, M., Rolo, A., Palmeira, C., et al. (2013). Therapeutic concentrations of mitoxantrone elicit energetic imbalance in H9c2 cells as an earlier effect. Cardiovascular Toxicology. doi: 10.1007\/s12012-013-9224-0 .","DOI":"10.1007\/s12012-013-9224-0"},{"key":"9230_CR9","first-page":"550","volume":"53","author":"NG Shipp","year":"1993","unstructured":"Shipp, N. G., Dorr, R. T., Alberts, D. S., Dawson, B. V., & Hendrix, M. (1993). Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells. Cancer Research, 53, 550\u2013556.","journal-title":"Cancer Research"},{"key":"9230_CR10","first-page":"194","volume":"52","author":"PM Alderton","year":"1992","unstructured":"Alderton, P. M., Gross, J., & Green, M. D. (1992). Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Research, 52, 194\u2013201.","journal-title":"Cancer Research"},{"key":"9230_CR11","first-page":"361","volume":"71","author":"E Bachmann","year":"1987","unstructured":"Bachmann, E., Weber, E., & Zbinden, G. (1987). Effect of mitoxantrone and doxorubicin on energy metabolism of the rat heart. Cancer Treatment Reports, 71, 361\u2013366.","journal-title":"Cancer Treatment Reports"},{"key":"9230_CR12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbabio.2011.04.002","volume":"1807","author":"AI Padr\u00e3o","year":"2011","unstructured":"Padr\u00e3o, A. I., Ferreira, R. M. P., Vitorino, R., Alves, R. M. P., Neuparth, M. J., Duarte, J. A., et al. (2011). OXPHOS susceptibility to oxidative modifications: The role of heart mitochondrial subcellular location. Biochimica et Biophysica Acta, 1807, 1106\u20131113.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9230_CR13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tox.2008.07.064","volume":"252","author":"H Pontes","year":"2008","unstructured":"Pontes, H., Duarte, J. A., De Pinho, P. G., Soares, M. E., Fernandes, E., Dinis-Oliveira, R. J., et al. (2008). Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice. Toxicology, 252, 64\u201371.","journal-title":"Toxicology"},{"key":"9230_CR14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00204-010-0630-9","volume":"85","author":"LG Rossato","year":"2011","unstructured":"Rossato, L. G., Costa, V. M., De Pinho, P. G., Carvalho, F., Bastos, M. L., & Remi\u00e3o, F. (2011). Structural isomerization of synephrine influences its uptake and ensuing glutathione depletion in rat-isolated cardiomyocytes. Archives of Toxicology, 85, 929\u2013939.","journal-title":"Archives of Toxicology"},{"key":"9230_CR15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1476-5381.2011.01453.x","volume":"165","author":"DJ Barbosa","year":"2012","unstructured":"Barbosa, D. J., Capela, J. P., Oliveira, J. M., Silva, R., Ferreira, L. M., Siopa, F., et al. (2012). Pro-oxidant effects of ecstasy and its metabolites in mouse brain synaptosomes. British Journal of Pharmacology, 165, 1017\u20131033.","journal-title":"British Journal of Pharmacology"},{"key":"9230_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O Lowry","year":"1951","unstructured":"Lowry, O., & Rosebrough, N. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265\u2013272.","journal-title":"Journal of Biological Chemistry"},{"key":"9230_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/toxsci\/57.1.177","volume":"57","author":"AP Rolo","year":"2000","unstructured":"Rolo, A. P., Oliveira, P. J., Moreno, A. J., & Palmeira, C. M. (2000). Bile acids affect liver mitochondrial bioenergetics: Possible relevance for cholestasis therapy. Toxicological Sciences, 57, 177\u2013185.","journal-title":"Toxicological Sciences"},{"key":"9230_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3109\/15376516.2011.576714","volume":"21","author":"FV Duarte","year":"2011","unstructured":"Duarte, F. V., Sim\u00f5es, A. M., Teodoro, J. S., Rolo, A. P., & Palmeira, C. M. (2011). Exposure to dibenzofuran affects lung mitochondrial function in vitro. Toxicology Mechanisms and Methods, 21, 571\u2013576.","journal-title":"Toxicology Mechanisms and Methods"},{"key":"9230_CR19","first-page":"138","volume":"2","author":"RD Patten","year":"2009","unstructured":"Patten, R. D., & Hall-Porter, M. R. (2009). Small animal models of heart failure: Development of novel therapies, past and present. Circulation, 2, 138\u2013144.","journal-title":"Circulation"},{"key":"9230_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00174155","volume":"3","author":"RF Novak","year":"1985","unstructured":"Novak, R. F., & Kharasch, E. D. (1985). Mitoxantrone: Propensity for free radical formation and lipid peroxidation-implications for cardiotoxicity. Investigational New Drugs, 3, 95\u201399.","journal-title":"Investigational New Drugs"},{"key":"9230_CR21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-3565(25)21617-2","volume":"226","author":"ED Kharasch","year":"1983","unstructured":"Kharasch, E. D., & Novak, R. F. (1983). Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation. Journal of Pharmacology and Experimental Therapeutics, 226, 500\u2013506.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"9230_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.0000137170.41939.d9","volume":"95","author":"JS Ingwall","year":"2004","unstructured":"Ingwall, J. S., & Weiss, R. G. (2004). Is the failing heart energy starved? On using chemical energy to support cardiac function. Circulation Research, 95, 135\u2013145.","journal-title":"Circulation Research"},{"key":"9230_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2003.055095","volume":"555","author":"R Ventura-Clapier","year":"2004","unstructured":"Ventura-Clapier, R., Garnier, A., & Veksler, V. (2004). Energy metabolism in heart failure. Journal of Physiology, 555, 1\u201313.","journal-title":"Journal of Physiology"},{"key":"9230_CR24","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1681\/ASN.V12suppl_1s15","volume":"12","author":"FC Luft","year":"2001","unstructured":"Luft, F. C. (2001). Lactic acidosis update for critical care clinicians. Journal of the American Society of Nephrology, 12, S15\u2013S19.","journal-title":"Journal of the American Society of Nephrology"},{"key":"9230_CR25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11886-000-0071-9","volume":"2","author":"PP Dzeja","year":"2000","unstructured":"Dzeja, P. P., Redfield, M. M., Burnett, J. C., & Terzic, A. (2000). Failing energetics in failing hearts. Current Cardiology Reports, 2, 212\u2013217.","journal-title":"Current Cardiology Reports"},{"key":"9230_CR26","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/sj.onc.1207936","volume":"23","author":"J Kluza","year":"2004","unstructured":"Kluza, J., Marchetti, P., Gallego, M.-A., Lancel, S., Fournier, C., Loyens, A., et al. (2004). Mitochondrial proliferation during apoptosis induced by anticancer agents: Effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene, 23, 7018\u20137030.","journal-title":"Oncogene"},{"key":"9230_CR27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BSR20090119","volume":"30","author":"SN Khan","year":"2010","unstructured":"Khan, S. N., Lai, S. K., Kumar, P., & Khan, A. U. (2010). Effect of mitoxantrone on proliferation dynamics and cell cycle progression. Bioscience Reports, 30, 375\u2013381.","journal-title":"Bioscience Reports"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-013-9230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-013-9230-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-013-9230-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T15:31:47Z","timestamp":1746027107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-013-9230-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,5]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["9230"],"URL":"https:\/\/doi.org\/10.1007\/s12012-013-9230-2","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,5]]}}}